biotech

5 Small-Cap Biotech Stocks Trading Under $10 With Massive Upside Potential
These five super-aggressive biotech stocks are all rated Buy at well-known Wall Street firms and are suitable for very aggressive investors that have a high-risk tolerance.
Lee Jackson
20 days ago

Is the Frequency Therapeutics Recovery a Dead Cat Bounce?
Frequency Therapeutics shares were absolutely crushed on Tuesday but saw a bit of a recovery early Wednesday.
Chris Lange
29 days ago

5 Stocks to Buy Under $10 With Explosive Upside Potential
Here are five stocks for aggressive investors looking to get share count leverage on companies that have sizable upside potential. They are not penny stocks with absolutely no track record or...
Lee Jackson
1 month ago

This Cancer Study Is a Gamechanger, and the Stock Practically Doubled
Rubius Therapeutics was one of Monday’s biggest winners after it announced initial data from its ongoing Phase 1/2 clinical trial of RTX-240 in patients with advanced solid tumors.
Chris Lange
1 month ago

Intranasal COVID-19 Vaccine Shows Very Promising Preclinical Results
Altimmune has announced additional preclinical data in regards to its single-dose intranasal COVID-19 vaccine candidate, AdCOVID.
Chris Lange
1 month ago

Novavax Could Have the Next Big COVID-19 Vaccine
Novavax stock jumped to close out the week after the firm announced the final efficacy numbers for its COVID-19 vaccine candidate.
Chris Lange
1 month ago

Amgen, Biogen, Gilead, Merck, Pfizer and More Health Care Earnings Coming This Week
Earnings season is in full swing, and we have put together a preview of some of the world’s largest players in the health care sector reporting this coming week.
Chris Lange
2 months ago
Last Updated: 2 months ago

Will Gritstone's COVID-19 Vaccine Be the Best One Yet?
Gritstone pushed higher on Tuesday after the company reported that it was advancing the development of a second-generation vaccine against SARS-CoV-2.
Chris Lange
3 months ago

Is Aclaris Therapeutics a Stock to Buy After Nearly 200% Run-Up and Now This?
Aclaris shares more than doubled to start out the week after the company announced positive results from its mid-stage rheumatoid arthritis study.
Chris Lange
3 months ago

Is Lexicon Pharma a Stock to Buy After 90% Runup and FDA Nod?
Lexicon Pharma shares jumped on Thursday morning after the company announced that it received regulatory feedback from the FDA regarding its heart failure treatment.
Chris Lange
3 months ago

Why Analysts Lost Confidence in the Arcturus COVID-19 Vaccine
Arcturus Therapeutics shares took a tumble on Tuesday after the company announced update on its COVID-19 vaccine candidate.
Chris Lange
3 months ago

Is Aprea Therapeutics Doomed?
Aprea Therapeutics stock was absolutely crushed to start out the week after the company announced results from its late-stage trial evaluating the safety and efficacy of its treatment for...
Chris Lange
3 months ago

Why This Recently Approved Prostate Cancer Treatment Could Be Huge for Myovant
Myovant shares shot up on Monday after the company announced a new collaboration with Pfizer for its tumor treatment across a couple of indications.
Chris Lange
3 months ago

How Big Is This Setback to Altimmune's COVID-19 Vaccine Candidate?
Altimmune shares dropped on Thursday after the company announced that it had received an update from the FDA regarding its COVID-19 vaccine candidate.
Chris Lange
3 months ago
Last Updated: 3 months ago

Agios Pharma's Big Bet on Anemia
Agios Pharmaceuticals shares jumped on Monday after the company announced that it will be streamlining its portfolio.
Chris Lange
4 months ago